Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

Avelas Biosciences raises funds to advance real-time cancer visualization technology

Jan. 13, 2014

Insight Genetics given phase II NCI contract for lung cancer resistance test

Jan. 13, 2014

Aggredyne gains FDA clearance for AggreGuide A-100 instrument and AA Assay

Jan. 10, 2014

Leica Biosystems to develop companion diagnostic for Arno's targeted oncology therapy onapristone

Jan. 10, 2014

Trovagene and US Oncology Research collaborate on urine-based KRAS testing study

Jan. 9, 2014

Qiagen launches therascreen IDH1/2 test for gliomas and collaborates with Mayo Clinic

Jan. 8, 2014

RadioMedix receives orphan drug designation for GalioMedix

Jan. 7, 2014

FDA clearance for AmpliVue Group B Strep assay

Dec. 31, 2013

Cellmid provides data from CK3000 study program

Dec. 20, 2013

Merck & Co. presents novel PET imaging agents for AD

Dec. 20, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...